期刊文献+

Expression of partial tandem duplication of mixed lineage leukaemia in patients with acute leukaemia and their relatives 被引量:3

Expression of partial tandem duplication of mixed lineage leukaemia in patients with acute leukaemia and their relatives
原文传递
导出
摘要 Background Partial tandem duplication of mixed lineage leukaemia (MLL-PTD) is detected both in patients with acute leukemia and in healthy people.However,MLL-PTD in relatives of patients with MLL-PTD has not been reported.The objective of this study was to investigate the expression of MLL-PTD in patients with acute leukemia and in their relatives.Methods The bone marrow or peripheral blood was collected from patients with acute leukaemia and their relatives.Nested reverse transcription-polymerase chain reaction (RT-PCR) was applied to detect the mRNA expression of the MLL-PTD fused gene,and further confirm in genomic DNA level.Results Analysing MLL-PTD in case 1,the patient's older brother and his younger brother were positive,while his mother and his son were negative.The exon type in case 1 was e9/3 fusion,but in his older brother,it was e9/3 and e11/3 fusion,and in his younger brother,it was e9/3,e10/3,and e11/3 fusion.MLL-PTD in case 2 was negative,but in the patient's older sister was positive,and the exon type was e9/3,e10/3,and e11/3.Conclusions The expression of MLL-PTD was present in cases with acute leukaemia with a single expression type.However,various expression types were detected in their healthy relatives.MLL-PTD can couple with other chromosome aberrations,and its impact on disease prognosis remains to be studied further. Background Partial tandem duplication of mixed lineage leukaemia (MLL-PTD) is detected both in patients with acute leukemia and in healthy people.However,MLL-PTD in relatives of patients with MLL-PTD has not been reported.The objective of this study was to investigate the expression of MLL-PTD in patients with acute leukemia and in their relatives.Methods The bone marrow or peripheral blood was collected from patients with acute leukaemia and their relatives.Nested reverse transcription-polymerase chain reaction (RT-PCR) was applied to detect the mRNA expression of the MLL-PTD fused gene,and further confirm in genomic DNA level.Results Analysing MLL-PTD in case 1,the patient's older brother and his younger brother were positive,while his mother and his son were negative.The exon type in case 1 was e9/3 fusion,but in his older brother,it was e9/3 and e11/3 fusion,and in his younger brother,it was e9/3,e10/3,and e11/3 fusion.MLL-PTD in case 2 was negative,but in the patient's older sister was positive,and the exon type was e9/3,e10/3,and e11/3.Conclusions The expression of MLL-PTD was present in cases with acute leukaemia with a single expression type.However,various expression types were detected in their healthy relatives.MLL-PTD can couple with other chromosome aberrations,and its impact on disease prognosis remains to be studied further.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第2期284-289,共6页 中华医学杂志(英文版)
关键词 MLL-PTD LEUKAEMIA healthy population TRANSPLANTATION chromosome aberration MLL-PTD leukaemia healthy population transplantation chromosome aberration
  • 相关文献

参考文献24

  • 1Nilson I,L(o)chner K,Siegler G,Greil J,Beck JD,Fey GH,et al. Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. Br J Haematol 1996; 93:966-972.
  • 2Caligiuri MA,Strout MP,Oberkircher AR,Yu F,de la Chapelle A,Bloomfield CD. The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome. Proc Natl Acad Sci USA 1997;94:3899-3902.
  • 3Schnittger S,Kinkelin U,Schoch C,Heinecke A,Haase D,Haferlach T,et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 2000; 14:796-804.
  • 4Whitman SP,Ruppert AS,Marcucci G,Mrózek K,Paschka P,Langer C,et al. Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication:a Cancer and Leukemia Group B study. Blood 2007; 109:5164-5167.
  • 5Weisser M,Kern W,Schoch C,Hiddemann W,Haferlach T,Schnittger S. Risk assessment by monitoring expression levels of partial tandem duplications in the MLL gene in acute myeloid leukemia during therapy. Haematologica 2005; 90:881-889.
  • 6Song J,Mercer D,Hu X,Liu H,Li MM. Common leukemiaand lymphoma-associated genetic aberrations in healthy individuals. J Mol Diagn 2011; 13:213-219.
  • 7Schnittger S,W(o)rmann B,Hiddemann W,Griesinger F. Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood 1998; 92:1728-1734.
  • 8B(a)secke J,Podleschny M,Clemens R,Schnittger S,Viereck V,Trümper L,et al. Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults. Leuk Res 2006; 30:1091-1096.
  • 9Schichman SA,Caligiuri MA,Gu Y,Strout MP,Canaani E,Bloomfield CD,et al. ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA 1994; 91:6236-6239.
  • 10Whitman SP,Liu S,Vukosavljevic T,Rush LJ,Yu L,Liu C,et al. The MLL partial tandem duplication:evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood 2005;106:345-352.

同被引文献13

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部